Next report date
—
Report period
—
EPS estimate
—
Revenue estimate
—
−0.0517USD
−12.13 MUSD
0.00USD
About VIVESTO AB
Vivesto AB engages in the research and development of drugs. It formulates pharmaceutical products for ovarian and breast cancer for humans and cancer for animals. The company was founded by Julian Aleksov and Bo Cederstrand in 1999 and is headquartered in Solna, Sweden.
Displays a symbol's price movements over previous years to identify recurring trends.